Published in Ginekol Pol on January 01, 1999
Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 1.53
Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta (2010) 1.50
The multifactorial role of leptin in driving the breast cancer microenvironment. Nat Rev Endocrinol (2011) 1.21
Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol (2012) 1.16
Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) (2009) 1.06
Plasma leptin levels and risk of breast cancer in premenopausal women. Cancer Prev Res (Phila) (2011) 1.00
Serum leptin levels, hormone levels, and hot flashes in midlife women. Fertil Steril (2009) 0.89
The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression. Front Oncol (2014) 0.84
Adiponectin and leptin molecular actions and clinical significance in breast cancer. Int J Hematol Oncol Stem Cell Res (2014) 0.83
Body mass index associated with genome-wide methylation in breast tissue. Breast Cancer Res Treat (2015) 0.81
Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers. Dis Markers (2015) 0.80
Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study. Breast Cancer Res (2006) 0.79
Mediators and moderators of the effects of a year-long exercise intervention on endogenous sex hormones in postmenopausal women. Cancer Causes Control (2011) 0.76
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell (1990) 17.60
Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab (2001) 1.26
Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J Clin Endocrinol Metab (1999) 1.15
Contraceptive efficacy and safety of DMPA-SC. Contraception (2004) 1.00
5alpha-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab (1999) 1.00
Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab (1996) 0.98
Stem cell factor and insulin-like growth factor-I stimulate luteinizing hormone-independent differentiation of rat ovarian theca cells. Biol Reprod (2001) 0.96
Leptin impairs the synergistic stimulation by transforming growth factor-beta of follicle-stimulating hormone-dependent aromatase activity and messenger ribonucleic acid expression in rat ovarian granulosa cells. Biol Reprod (1999) 0.93
Inhibin A, inhibin B and activin A in the follicular fluid of regularly cycling women. Hum Reprod (1997) 0.91
Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol Hum Reprod (1998) 0.91
Insulin-like growth factor-I stimulates the expression of 3 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid in ovarian theca-interstitial cells. Biol Reprod (1993) 0.86
Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome. Hum Reprod (1998) 0.84
Differentiation of ovarian theca-interstitial cells in vitro: regulation of 17 alpha-hydroxylase messenger ribonucleic acid expression by luteinizing hormone and insulin-like growth factor-I. Endocrinology (1993) 0.82
Insulin-like growth factor-I regulation of luteinizing hormone (LH) receptor messenger ribonucleic acid expression and LH-stimulated signal transduction in rat ovarian theca-interstitial cells. Biol Reprod (1994) 0.82
Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries. Mol Hum Reprod (2004) 0.81
Hepatocyte growth factor regulates ovarian theca-interstitial cell differentiation and androgen production. Endocrinology (1997) 0.80
Effect of insulin-like growth factor-I on cholesterol side-chain cleavage cytochrome P450 messenger ribonucleic acid expression in ovarian theca-interstitial cells stimulated to differentiate in vitro. Mol Cell Endocrinol (1993) 0.80
Transforming growth factor-beta inhibits ovarian 17 alpha-hydroxylase activity by a direct noncompetitive mechanism. Endocrinology (1996) 0.79
Insulin-like growth factor-1 (IGF-1) stimulates the IGF binding protein system in rat theca interstitial cells. Endocrine (1995) 0.78
Serum leptin concentrations in women taking oral contraceptives. Eur J Obstet Gynecol Reprod Biol (1999) 0.78
Leptin gene expression in subcutaneous adipose tissue in girls before and during puberty. Eur J Obstet Gynecol Reprod Biol (2006) 0.77
[Aromatase (P450AROM) mRNA expression in normal, hyperplastic and malignant endometrium and aromatase activity in endometrial cancer tissue culture]. Ginekol Pol (2000) 0.77
Expression of the long (OB-RB) and short (OB-RA) forms of the leptin receptor throughout the oestrous cycle in the mature rat ovary. Reproduction (2002) 0.76
Evaluation of matrix metalloproteinases-1 and -3 concentrations in the tunica albuginea, the apical wall of atretic follicles and the corpus luteum of normal human ovaries. Gynecol Endocrinol (2000) 0.76
Leptin correlates with the skinfold thickness in prepubertal and pubertal girls. Acta Paediatr (1999) 0.75
Accuracy and diagnostic value of outpatient hysteroscopy for malign and benign disease. Eur J Gynaecol Oncol (2014) 0.75
Interstitial collagenase (MMP-1) activity in human ovarian tissue. Gynecol Endocrinol (1999) 0.75